 So in principle, I think if we ignore the problem of blinding, which I'll get to in a moment, the MAP study, the two studies, MAP1 and MAP2, were designed in a way, interestingly. You have an idea, you think that MDMA combined with psychotherapy helps people more than nothing combined with psychotherapy, which is state of the art, right? At least for many mood and anxiety disorders.